Advances in Regenerative Medicine in Disease Treatment: Harnessing Potential and Bridging Challenges

Dear Colleagues,

Regenerative medicine exhibits the remarkable potential to treat previously incurable diseases by restoring tissue and organ function. Recent breakthroughs in stem cells, biomaterials, molecular therapies, and tissue engineering have unlocked novel clinical translation pathways. However, realizing this potential requires various challenges related to safety, efficacy, scalability, and regulation to be overcome.

This Special Issue aims to provide an overview of innovative research in regenerative research that accelerates the development of transformative therapies. The scope of this Special Issue includes, but is not limited to, the following topics:

• Elucidating molecular mechanisms guiding tissue regeneration and disease pathogenesis;
• Crafting targeted delivery systems enabling precise and safe therapeutics;
• Strategies to modulate immunity for enhanced repair while reducing rejection;
• Personalized approaches for individualized precision medicine.

By collating relevant insights, we aim to highlight the biological complexities that warrant further investigation while also conveying regenerative medicine’s capacity to treat injuries, degenerative conditions, and genetic disorders. This Special Issue will be particularly valuable to researchers and clinicians aiming to integrate regenerative techniques and biotechnology, as well as regulatory/policy professionals.

Dr. Edward H. Ntege
Prof. Dr. Adrian Neagu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.